| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000223695.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027734818 |
Resistant |
| ENSG00000223695.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.000442159 |
Resistant |
| ENSG00000223695.1 |
Axitinib |
Breast invasive carcinoma |
0.014457589 |
Sensitive |
